ALEMBICLTD / NSE / Biotechnology & Drugs
Alembic
1Y Price Trend
Key Information
Recommendations
Target High125.7
Target Low70.64
Target Mean0
Target Median0
Risk Metrics
Overall RiskBalanced risk
Board Risk32.72
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg EquityBulls
Alembic Pharmaceuticals in Focus After Receiving USFDA Approval For Drug With $27 Million Market Opportunity Trade Brains
Alembic Pharma Gets USFDA Approval For Haloperidol Tablets; Shares Rise HDFC Sky
Alembic Ltd Technical Momentum Shifts Amid Bearish Outlook Markets Mojo
Alembic Ltd is Rated Sell by MarketsMOJO Markets Mojo
Alembic Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo
Alembic Ltd Technical Momentum Shifts Amid Bearish Outlook Markets Mojo
Alembic Ltd is Rated Sell by MarketsMOJO Markets Mojo
© SharekeyX | Rusaka Technologies 2024-2026